ElevateBio is accelerating the rate of innovation in cell and gene therapy with a disruptive capital-efficient model

Elevate right from the start.

We provide the tools, time, and environment to innovate and accelerate development of life-saving therapies

Pioneering science

Together with scientific innovators and our strategic partners, we are rapidly building a diverse portfolio of companies advancing immunotherapies, regenerative medicine products, in vivo viral-based therapies, and other cutting-edge cell and gene therapies from preclinical to commercialization.

Advancing technology

We’re pioneering new methods to develop next generation, cell, viral, and regenerative therapies. We offer expertise to our portfolio companies and partners to accelerate the development of cell and gene therapies, from cGMP manufacturing suites to protein engineering, virology, and immunology labs.

what is basecamp?

BaseCamp provides a home for scientific founders to elevate their vision

ElevateBio BaseCamp – the heart of our operations – is a dedicated cell and gene therapy research, process development, and production center that addresses the primary obstacles in cell and gene therapy and regenerative medicine: integrated research, process development and manufacturing.

Enabled By

ElevateBio

Our portfolio companies benefit from our entrepreneurial and flexible culture. We accelerate early-stage companies through capital and expertise, allowing them to focus on science, research, and development.

Innovator in T-Cell Immunotherapies Established Out of Technology from the Baylor College of Medicine’s Center for Cell and Gene Therapy

Learn More

Novel T Cell Immunotherapies Being Developed with Technology from The Fred Hutchinson Cancer Center



Highly innovative genome editing technology platform accelerates and broadens ElevateBio’s cell and gene therapy enabling technologies

LEarn more

News

& Media

Stay up to date with news from our research, process development, cGMP manufacturing, clinical development, regulatory affairs, and commercial operations.

November 15, 2021

ElevateBio Announces Issuance of U.S. Patent Providing Protection for RNA-Guided Nucleases Identified through its Life Edit Gene Editing Platform

November 15, 2021

ElevateBio Announces Issuance of U.S. Patent Providing Protection for RNA-Guided Nucleases Identified through its Life Edit Gene Editing Platform

October 27, 2021

ElevateBio Supercharges Gene Editing and Therapeutic Product Development Capabilities Through Acquisition of Life Edit Therapeutics

June 29, 2021

Boston Children’s Hospital and ElevateBio Announce Five-Year Cell and Gene Therapy Collaboration

June 10, 2021

ElevateBio Announces Margo Roberts, Ph.D. Joins as Scientific Advisor for Company’s Immunotherapy Platform Expansion

April 27, 2021

ElevateBio’s BaseCamp Selected as the 2021 Facility of the Year Award Category Winner for Operational Excellence by the International Society for Pharmaceutical Engineering